The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 30, 2005
Filed:
Apr. 19, 2002
Henrik S. Olsen, Gaithersburg, MD (US);
Haodong LI, Gaithersburg, MD (US);
Mark D. Adams, Rockville, MD (US);
Solange H. L. Gentz, Rockville, MD (US);
Ralph Alderson, Gaithersburg, MD (US);
Yuling LI, Germantown, MD (US);
David Parmelee, Rockville, MD (US);
John R. White, Coatesville, PA (US);
Edward R. Appelbaum, Blue Bell, PA (US);
Henrik S. Olsen, Gaithersburg, MD (US);
Haodong Li, Gaithersburg, MD (US);
Mark D. Adams, Rockville, MD (US);
Solange H. L. Gentz, Rockville, MD (US);
Ralph Alderson, Gaithersburg, MD (US);
Yuling Li, Germantown, MD (US);
David Parmelee, Rockville, MD (US);
John R. White, Coatesville, PA (US);
Edward R. Appelbaum, Blue Bell, PA (US);
Human Genome Sciences, Inc., Rockville, MD (US);
SmithKline Beecham Corp., King of Prussia, PA (US);
Abstract
Human chemokine Beta-10 polypeptides and DNA (RNA) encoding such chemokine polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such chemokine polypeptides for the treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, wound healing and psoriasis. Antagonists against such chemokine polypeptides and their use as a therapeutic to treat rheumatoid arthritis, autoimmune and chronic inflammatory and infective diseases, allergic reactions, prostaglandin-independent fever and bone marrow failure are also disclosed.